Browse by ["viewname_eprint_publisher" not defined]

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type | No Grouping
Jump to: B | G | H | P | W
Number of items at this level: 19.

B

Beier, D. and Hau, P. and Jauch, T. and Beier, C. and Gänßbauer, S. and Glas, M. and Koch, H. and Wismeth, C. and Steinbrecher, A. and Bogdahn, U. (2006) Combined regimen of temozolomide and liposomal pegylated doxorubicin in glioblastoma: Toxicity and efficacy - An update. NEURO-ONCOLOGY, 8 (4). pp. 347-348. ISSN 1522-8517

Beier, D. and Hau, P. and Jauch, T. and Koch, D. and Hundsberger, T. and Schuth, S. and Bogdahn, U. (2005) Long-term treatment with temozolomide in high-grade gliomas is feasible and leads to long-term survival in a significant subset of patients. In: 2nd Quadrennial Meeting of the World Federation of Neuro-Oncology/Sixth Meeting of the European Association for Neuro-Oncology, May 05-08, 2005, Edinburgh, Scotland.

Beier, D. and Hau, P. and Proescholdt, M. and Lohmeier, A. and Aigner, L. and Brawanski, A. and Bogdahn, U. and Beier, C. P. (2006) CD133+ and CD133- Cancer stem cells in glioblastoma. NEURO-ONCOLOGY, 8 (4). p. 317. ISSN 1522-8517

Beier, D. and Roehrl, S. and Pillai, D. R. and Schwarz, S. and Kunz-Schughart, L. and Proescholdt, M. and Brawanski, A. and Bogdahn, U. and Wischhusen, J. and Reifenberger, G. and Hau, P. and Beier, C. P. (2008) TEMOZOLOMIDE INDUCES SELECTIVE DEPLETION OF CANCER STEM CELLS IN HUMAN GLIOBLASTOMAS. In: 8th Congress of the European Association for Neuro-Oncology (EANO), September 12-14, 2008, Barcelona, Spain.

Bogdahn, U. and Mahapatra, A. K. and Oliushine, V. E. and Mouli, C. and Parfenov, V. E. and Stockhammer, G. and Ludwig, S. and Wuerth, G. and Heinrichs, H. and Schlingensiepen, K. H. (2008) TARGETED THERAPY WITH AP 12009 FOR RECURRENT OR REFRACTORY HIGH-GRADE GLIOMA: RESULTS UPDATE OF A PHASE IIB STUDY. In: 8th Congress of the European Association for Neuro-Oncology (EANO), September 12-14, 2008, Barcelona, Spain.

Bogdahn, U. and Parfenov, V. E. and Oliushine, V. and Kunst, M. and Mahaparra, A. and Sastry, K. and Venkataramana, N. K. and Jachimczak, P. and Hau, P. and Schlingensiepen, K. (2006) Results of a phase IIB actively controlled clinical trial in patients with recurrent malignant glioma. NEURO-ONCOLOGY, 8 (4). p. 305. ISSN 1522-8517

Bogdahn, Ulrich and Rappaport, Z. H. and Stockhammer, Guenther and Oliushine, Victor and Parfenov, Valery and Mahapatra, Ashok and Mouli, Chandra and Venkataramana, K. Neelam and Heinrichs, Hubert and Schlingensiepen, Karl-Herrmann (2007) Targeted therapy with AP 12009 for recurrent or refractory high-grade glioma: Results of a phase IIB study. NEURO-ONCOLOGY, 9 (4). pp. 520-521. ISSN 1522-8517

G

Glas, M. and Hirschmann, B. and Steinbrecher, A. and Hau, P. and Bogdahn, U. (2006) Somatostatin analogues as second-line treatment in adult patients with recurrent medulloblastoma: A case report and a concept for a multicentric, open-label, proof-of-concept, phase I study. NEURO-ONCOLOGY, 8 (4). p. 341. ISSN 1522-8517

Glas, M. and Koch, H. and Hirschmann, B. and Jauch, T. and Steinbrecher, A. and Bogdahn, U. and Hau, P. (2006) Pegylated liposomal doxorubicin in recurrent high-grade glioma: Comparison of clinical trial results and compassionate use. NEURO-ONCOLOGY, 8 (4). pp. 353-354. ISSN 1522-8517

Grauer, O. M. and Molling, J. W. and Sutmuller, R. P. M. and Nierkens, S. and Adema, G. J. (2008) CPG-OLIGONUCLEOTIDES ARE SUPERIOR TO OTHER TLR LIGANDS IN THE LOCAL TREATMENT OF ESTABLISHED INTRACEREBRAL MURINE GLIOMAS. In: 8th Congress of the European Association for Neuro-Oncology (EANO), September 12-14, 2008, Barcelona, Spain.

H

Hau, P. and Grisold, W. and Mahapatra, M. and Mehdorn, M. and Parfenov, V. E. and Pichler, J. and Zaaroor, M. and Bogdahn, U. and Schlingensiepen, K. H. (2005) The TGF-beta2 specific antisense oligonucleotide AP 12009 as immunotherapy in high-grade glioma: A clinical phase IIB study. In: 2nd Quadrennial Meeting of the World Federation of Neuro-Oncology/Sixth Meeting of the European Association for Neuro-Oncology, May 05-08, 2005, Edinburgh, Scotland.

Hau, P. and Jauch, T. and Baumgart, U. and Beier, D. and Gänßbauer, S. and Koch, H. and Wismeth, C. and Steinbrecher, A. and Bogdahn, U. (2005) Adjuvant chemotherapy with temozolomide and liposomal doxorubicine in the first-line therapy of patients with glioblastoma: A phase 2 trial. In: 2nd Quadrennial Meeting of the World Federation of Neuro-Oncology/Sixth Meeting of the European Association for Neuro-Oncology, May 05-08, 2005, Edinburgh, Scotland.

P

Pels, H. and Juergens, A. and Glasmacher, A. and Schulz, H. and Vogt-Schaden, M. and Lamprecht, M. and Reichmann, H. and Bogdahn, U. and Schmidt-Wolf, I. G. H. and Schlegel, U. (2006) Modified "Bonn protocol" without intraventricular chemotherapy in the treatment of primary CNS lymphoma: Preliminary results. NEURO-ONCOLOGY, 8 (4). pp. 301-302. ISSN 1522-8517

W

Wick, A. and Pascher, C. and Wick, W. and Weller, M. and Bogdahn, U. and Hau, P. (2008) RECHALLENGE WITH TEMOZOLOMIDE IN RECURRENT GLIOMAS. In: 8th Congress of the European Association for Neuro-Oncology (EANO), September 12-14, 2008, Barcelona, Spain.

Wismeth, C. and Gänßbauer, S. and Hau, P. and Hirschmann, B. and Glas, M. and Beier, C. and Beier, D. and Steinbrecher, A. and Bogdahn, U. (2006) Locoregional hyperthermia in patients with progressive astrocytoma WHO III or glioblastoma WHO IV (RNOP-10): A prospective single-arm phase I/II study. NEURO-ONCOLOGY, 8 (4). p. 351. ISSN 1522-8517

Wismeth, C. and Hau, P. and Jauch, T. and Hirschmann, B. and Gänßbauer, S. and Steinbrecher, A. and Bogdahn, U. (2006) Neoadjuvant therapy with temozolomide and 13-cis-retinoic acid in malignant glioma (RNOP-05): A phase II study. NEURO-ONCOLOGY, 8 (4). pp. 345-346. ISSN 1522-8517

Wolff, J. E. A. and Kutluk, T. and Wrede, B. (2006) Choosing drugs for choroid plexus carcinoma treatment. NEURO-ONCOLOGY, 8 (4). p. 339. ISSN 1522-8517

Wolff, J. E. A. and Wagner, S. and Classen, C. F. and Kortmann, R. D. and Pietsch, T. and Gnekow, A. (2006) Response in pediatric high-grade glioma: What does it mean? NEURO-ONCOLOGY, 8 (4). pp. 308-309. ISSN 1522-8517

Wolff, J. E. A. and Wagner, S. and Rutkowski, S. and Ater, J. L. and Kortmann, R. and Pietsch, T. and Gnekow, A. (2006) Quality control and high-grade glioma treatment for children: What is necessary? Analysis of the HIT-GBM database. NEURO-ONCOLOGY, 8 (4). pp. 309-310. ISSN 1522-8517

This list was generated on Wed Jul 29 13:39:28 2026 CEST.